1842PForetinib circumvents the NTRK1 G667C mutation-associated entrectinib-resistance in the brain and liver metastases produced by NTRK1 fusion-positive tumor cells. (23rd October 2018) - Yano, S; Nishiyama, A; Kita, K; Takeuchi, S